These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26741872)

  • 1. Common Misconceptions, Advancements, and Updates in Pediatric Vaccination Administration.
    Oldfield BJ; Stewart RW
    South Med J; 2016 Jan; 109(1):38-41. PubMed ID: 26741872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hib antibody responses in infants following diphtheria, tetanus, acellular pertussis, and conjugated Haemophilus influenzae type b (Hib) combination vaccines with decreasing amounts of tetanus toxoid.
    Bernstein HH; Seyferth ER
    Vaccine; 2017 Dec; 35(48 Pt B):6707-6711. PubMed ID: 29054729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pediatric disease burden and vaccination recommendations: understanding local differences.
    Gentile A; Bhutta Z; Bravo L; Samy AG; Garcia RD; Hoosen A; Islam T; Karimi A; Salem M; Simasathien S; Sohail A; Watanaveeradej V; Wiedenmayer K; Schmitt HJ
    Int J Infect Dis; 2010 Aug; 14(8):e649-58. PubMed ID: 20181506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A combined diphtheria, tetanus, five-component acellular pertussis, poliovirus and Haemophilus influenzae type b vaccine.
    Black S; Greenberg DP
    Expert Rev Vaccines; 2005 Dec; 4(6):793-805. PubMed ID: 16372875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experiences with a new combined vaccine against B. parapertussis, diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10.
    Buriănová-Vysoká B; Burian V; Kriz B; Pellar T; Hellerová J; Radkovský J
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(4):481-7. PubMed ID: 4321988
    [No Abstract]   [Full Text] [Related]  

  • 8. 10 Practice Recommendations in Adult Vaccination Administration.
    Oldfield BJ; Stewart RW
    South Med J; 2016 Feb; 109(2):87-90. PubMed ID: 26840962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
    Pool V; Tomovici A; Johnson DR; Greenberg DP; Decker MD
    Vaccine; 2018 Apr; 36(17):2282-2287. PubMed ID: 29573876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, reactogenicity and immunogenicity of a combined hexavalent tetanus, diphtheria, acellular pertussis, hepatitis B, inactivated poliovirus vaccine and Haemophilus influenzae type b conjugate vaccine, for primary immunization of infants.
    Zepp F; Knuf M; Heininger U; Jahn K; Collard A; Habermehl P; Schuerman L; Sänger R
    Vaccine; 2004 Jun; 22(17-18):2226-33. PubMed ID: 15149781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnitude of interference after diphtheria-tetanus toxoids-acellular pertussis/Haemophilus influenzae type b capsular polysaccharide-tetanus vaccination is related to the number of doses administered.
    Daum RS; Zenko CE; Given GZ; Ballanco GA; Parikh H; Germino K
    J Infect Dis; 2001 Nov; 184(10):1293-9. PubMed ID: 11679918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ongoing control of Haemophilus influenzae type B infections in Canadian children, 2004-2007.
    Scheifele DW; Bettinger JA; Halperin SA; Law B; Bortolussi R
    Pediatr Infect Dis J; 2008 Aug; 27(8):755-7. PubMed ID: 18594482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
    Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
    Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DTaP5-HB-IPV-Hib Vaccine (Vaxelis
    Syed YY
    Paediatr Drugs; 2017 Feb; 19(1):69-80. PubMed ID: 28035545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive swelling reaction associated with diphtheria and tetanus toxoids and acellular pertussis vaccine.
    Sekaran NK; Edwards KM
    Pediatr Infect Dis J; 2006 Apr; 25(4):374-5. PubMed ID: 16567996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UK health officials launch "five in one" vaccine for babies.
    Dobson R
    BMJ; 2004 Aug; 329(7462):365. PubMed ID: 15310591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined vaccination of children against whooping cough, diphtheria and tetanus].
    Ned Tijdschr Geneeskd; 1953 Mar; 97(11):695-7. PubMed ID: 13063630
    [No Abstract]   [Full Text] [Related]  

  • 19. Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies.
    Boef AGC; van der Klis FRM; Berbers GAM; Buisman AM; Sanders EAM; Kemmeren JM; van der Ende A; de Melker HE; Rots NY; Knol MJ
    Vaccine; 2018 Jan; 36(3):400-407. PubMed ID: 29223483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the immunogenicity and safety of pentavalent vaccine Quinvaxem in a compact prefilled auto-disabled (cPAD) injection system versus single-dose vials in healthy infants: a phase 3, open-label, randomized, parallel-group, non-inferiority study.
    Capeding MR; Alberto E; Versteilen A; Rauscher M; Bagchi P; Palacios PI
    Int J Infect Dis; 2016 May; 46():71-8. PubMed ID: 26923083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.